跳至主要内容
临床试验/NCT03849274
NCT03849274已完成早期 1 期

Effectiveness of a Combined Adequate Pressure and Silicone Intervention in Comparison With Conventional Pressure for Hypertrophic Scar Treatment

Chinese University of Hong Kong1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2020年1月31日最近更新:
适应症

试验速览

阶段
早期 1 期
状态
已完成
入组人数
60
试验地点
1
主要终点
Changes from baseline hypertrophic Scar Thickness at 1 months post-surgical to total knee/hip arthroplasty

研究概览

简要总结

Pressure therapy (PT) and silicone therapy are recommended as first-line non-invasive treatment for Hypertrophic Scar (HS), yet the effectiveness of the combination of these two treatments through an RCT trial has not been established yet. This study aims to examine the effectiveness of the combination of adequate pressure therapy and silicone gel sheeting implemented by Smart Scar Care Pad (SSCP) + conventional Pressure Garment (PG) versus conventional Pressure Garment (PG) alone in the management of HS in adult with total hip replacement (THR) and total knee replacement (TKR). This study also aims to find out the prevalence of hypertrophic scar among patients with THR and TKR. This study is a randomised controlled trial with two parallel arms, with allocation ratio (Experimental: Control) of 1: 1 in order to establish the superiority of SSCP + PG over PG. Subjects with hypertrophic scar will be randomly assigned to either treatment or control group. The subjects in the treatment group will be provided with the SSCP and PG for treatment, whereas the subjects in the control group will be prescribed only the PG. The treatment will last for a total of 6 months. A variety of objective outcome measures will be used to analysis the treatment effect.

详细描述

Hypertrophic scar (HS) is a challenging yet common complication of dermal injuries such as burns, surgeries, and trauma. It is characterized as a raised, rigid, hyper-vascular, and abnormally pigmented scar confined within the border of the initial injury. The induced aesthetic defect and impaired physical function could adversely affect quality of life.1 Pressure therapy (PT) and silicone therapy are recommended as first-line non-invasive treatments HS.

Recent reviews suggested PT was able to decrease scar height and erythema3,4. The inconclusive outcome results from fact that seldom research address the issue of adequate pressure dosage, which is essential for the treatment effect of PT. It is recommended that an interface pressure of 15-25 mmHg should be given and maintained through a 23 hrs/day wearing regime in order to achieve optimal treatment outcomes5. However, maintaining adequate pressure dosage through pressure garment alone is usually uncomfortable and sometimes impossible, especially over bodily concave area. Therefore, pressure inserts are used in conjunction with pressure garment to increase local pressure6. Despite the documented use of pressure inserts in various journals, pressure garment alone remains the mainstream treatment for hypertrophic scar.

Cochrane review conducted on silicone gel sheet (SGS) revealed SGS's ability in reducing scar thickness and improving scar color, but insufficient data on its effect on scar pliability5. SGS are commonly used to occlude and provide hydration to scar tissues.5, 6 They are mainly used for small scars or surgical scars. They are generally costly and thin in physical form, rendering them incapable of exerting sufficient pressure.

The joint effectiveness of these two treatment modalities in scar management is always drawing the interests from researchers. Various studies reported that enhanced effectiveness could be achieved through the combination of PT and SGS especially in terms of scar pliability, though all subjectively measured6-8. Therefore, there is an urging need to establish the effectiveness of the combination of these two treatments through an RCT.

In order to address the adequate pressure as well as the silicone gel sheeting effect at the same time, a newly invented insert material, the Smart Scar Care Pad (SSCP), is adopted in this study as treatment modality. The Smart Scar Care Pad is especially designed with a rubbery silicone stiffener layer and medical grade silicone gel lining layer underneath. The medical grade silicone gel lining layer underneath serves as the occlusion layer. The rubbery silicone stiffener layer is designed with numerous studs. By cutting the individual studs into gradient height, the Smart Scar Care Pad (SSCP), creates tailor made localized pressure under pressure garment. Studs are also aligned in honey cone style in order to maximize conformability over different bodily contours. In that case, the Smart Scar Care Pad (SSCP) not only increases local pressure but also provides occlusion to HS tissue.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

All subjects will be asked to removed all the treatment materials before they entered the assessment rooms to ensure the blinding of the assessor. The ultrasound data will be processed and analysed by blinded analysts.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult (age over 18 years old) undergoing TKR and THR within 6 weeks;
  • Adult who is able to provide written consent, is cooperative and compliant with the treatment and assessment regime;
  • The Vancouver Scar Scale (VSS) will be used to screen candidates for the study.10 Isolated scars with a total score of 4 or higher and the score of each item equal to or greater than 1 will be included.

排除标准

  • The HS area has an open wound or infection, or HS area is local flap or skin graft area;
  • The HS area intends to be treated with steroid injections or other interventions (such as traditional Chinese medicine or laser therapy)
  • The patients with co-morbidities that might affect their compliance to treatment such as dermatological disorders.

结局指标

主要结局

Changes from baseline hypertrophic Scar Thickness at 1 months post-surgical to total knee/hip arthroplasty

时间窗: 1 month post total knee/hip arthroplasty operation

Using an ultrasound machine, thickness of scar is aggregately measured to the average of 3 points: the center of the inner ring, 5 mm on both side of the centre point, which reflected the points of circumference of the selected scar sites.

Changes from baseline hypertrophic Scar Thickness at 3 months post-surgical to total knee/hip arthroplasty

时间窗: 3 month post total knee/hip arthroplasty operation

Using an ultrasound machine, thickness of scar is aggregately measured to the average of 3 points: the center of the inner ring, 5 mm on both side of the centre point, which reflected the points of circumference of the selected scar sites.

Changes from baseline hypertrophic Scar Thickness at 6 months post-surgical to total knee/hip arthroplasty

时间窗: 6 month post total knee/hip arthroplasty operation

Using an ultrasound machine, thickness of scar is aggregately measured to the average of 3 points: the center of the inner ring, 5 mm on both side of the centre point, which reflected the points of circumference of the selected scar sites.

次要结局

  • Changes of scar vascularity and pigmentation at 1 month post-surgical to total knee/hip arthroplasty(1 month post total knee/hip arthroplasty operation)
  • Changes of scar vascularity and pigmentation at 3 months post-surgical to total knee/hip arthroplasty(3 months post total knee/hip arthroplasty operation)
  • Changes of scar vascularity and pigmentation at 6 month post-surgical to total knee/hip arthroplasty(6 month post total knee/hip arthroplasty operation)
  • Changes of scar elasticity at 1 month post-surgical to total knee/hip arthroplasty(1 month post total knee/hip arthroplasty operation)
  • Changes of scar elasticity at 3 months post-surgical to total knee/hip arthroplasty(3 months post total knee/hip arthroplasty operation)
  • Changes of scar elasticity at 6 months post-surgical to total knee/hip arthroplasty(6 months post total knee/hip arthroplasty operation)
  • Changes of range of motion (ROM) of knee joint or hip joint at 1 month post-surical to total knee/hip arthroplasty(1 month post total knee/hip arthroplasty operation)
  • Changes of range of motion (ROM) of knee joint or hip joint at 3 months post-surical to total knee/hip arthroplasty(3 months post total knee/hip arthroplasty operation)
  • Changes of range of motion (ROM) of knee joint or hip joint at 6 months post-surical to total knee/hip arthroplasty(6 months post total knee/hip arthroplasty operation)
  • Changes of circumference measurement of knee joint or hip joint at 1 month post-surgical to total knee/hip arthroplasty(1 month post-surgical to total knee/hip arthroplasty)
  • Changes of circumference measurement of knee joint or hip joint at 3 months post-surgical to total knee/hip arthroplasty(3 months post-surgical to total knee/hip arthroplasty)
  • Changes of circumference measurement of knee joint or hip joint at 6 months post-surgical to total knee/hip arthroplasty(6 months post-surgical to total knee/hip arthroplasty)
  • Changes of pain/itchiness sensation at 1 month post-surgical to total knee/hip arthroplasty(1 month post-surgical to total knee/hip arthroplasty)
  • Changes of pain/itchiness sensation at 3 months post-surgical to total knee/hip arthroplasty(3 months post-surgical to total knee/hip arthroplasty)
  • Changes of pain/itchiness sensation at 6 months post-surgical to total knee/hip arthroplasty(6 months post-surgical to total knee/hip arthroplasty)
  • Changes of The 36-Item Short Form Health Survey (SF-36) index at 1 month post-surgical to total knee/hip arthroplasty(1 month post-surgical to total knee/hip arthroplasty)
  • Changes of The 36-Item Short Form Health Survey (SF-36) index at 3 months post-surgical to total knee/hip arthroplasty(3 months post-surgical to total knee/hip arthroplasty)
  • Changes of The 36-Item Short Form Health Survey (SF-36) index at 6 months post-surgical to total knee/hip arthroplasty(6 months post-surgical to total knee/hip arthroplasty)
  • Changes of treatment satisfaction value at 1 month post-surgical to total knee/hip arthroplasty(1 month post-surgical to total knee/hip arthroplasty)
  • Changes of treatment satisfaction value at 3 months post-surgical to total knee/hip arthroplasty(3 months post-surgical to total knee/hip arthroplasty)
  • Changes of treatment satisfaction value at 6 months post-surgical to total knee/hip arthroplasty(6 months post-surgical to total knee/hip arthroplasty)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Ho Ki Wai

Clinical Professional Consultant

Chinese University of Hong Kong

研究点 (1)

Loading locations...

相似试验